I3LUNG: Integrative Science, Intelligent Data Platform for Individualized LUNG Cancer Care With Immunotherapy

Clinical trial NCT05537922 · RECRUITING

Trial details

NCT number: NCT05537922
Sponsor: Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
Status: RECRUITING
Study type: OBSERVATIONAL

Non Small Cell Lung Cancer Lung Cancer Metastatic Lung Cancer, Nonsmall Cell Lung Adenocarcinoma

Start date: 2022-10-01
Primary completion: 2025-10-01
Enrollment: 2200

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.